Elsevier

Brain Research Bulletin

Volume 48, Issue 2, 15 January 1999, Pages 219-222
Brain Research Bulletin

Original Articles
Interaction of benztropine and haloperidol actions on rat substantia nigra dopamine cell electrophysiological activity in vivo

https://doi.org/10.1016/S0361-9230(98)00166-XGet rights and content

Abstract

Despite the known efficacy of antimuscarinic agents in treating dopamine-related movement disorders, their effects on dopamine cell activity have not been well studied. We investigated the effects of systemically administered benztropine, an antimuscarinic agent that also inhibits the dopamine transporter, on substantia nigra dopamine neuron electrophysiological activity. Benztropine caused a dose-dependent inhibition of the firing rate of dopamine neurons in control rats but exerted baseline-dependent changes in burst firing. In rats pretreated with haloperidol, which prevents the effects of dopamine transporter inhibitors on dopamine cell activity, benztropine either increased or decreased firing rate; however, it consistently increased burst firing. Thus, the antimuscarinic and psychostimulant properties of benztropine have differential effects on dopamine neuron firing rate and burst firing. The increase in burst firing seen in the presence of haloperidol may mediate some of the therapeutic effects of benztropine in the treatment of antipsychotic drug-induced movement disorders.

Introduction

Antipsychotic drugs (APDs) are the most effective treatments available for schizophrenia. Unfortunately, these drugs can also cause extrapyramidal side effects [1], probably via their action on dopamine (DA) neurons [4] and at DA receptors [6] in the basal ganglia. One of these side effects is an acute dystonic reaction (ADR), which involves abnormal and tonic contractions of neck and facial muscles, often with torticollis and oculogyric crises [23]. Acute dystonic reactions occur only in the first 4 days of APD treatment, often in young males treated with high doses of high-potency neuroleptics such as haloperidol (HAL), fluphenazine or trifluoperazine. The treatment of ADRs is often achieved with antimuscarinic compounds such as benztropine (BENZ) 22, 23, 27, which also inhibits the DA transporter 8, 11, 15, 16. However, to date, the effects of this class of drugs on DA cell activity have not been investigated.

It has been known for some time that APDs affect the electrophysiological activity of DA neurons of the substantia nigra (SN) and ventral tegmental area (VTA) [5]. When administered acutely, APDs increase DA cell firing rate and bursting activity by blocking somatodendritic DA autoreceptors [21]. In addition, DA neuron activity is affected by muscarinic drugs 17, 18 as well as dopamine transporter (DAT) inhibitors 2, 12, 13, 24. Given the effects of APDs, DAT inhibitors, and muscarinic drugs on midbrain DA neuron activity, and the efficacy of BENZ in the treatment of APD-induced ADRs, we investigated the interaction between BENZ and HAL on DA neuron activity in anesthetized rats. A portion of these data has been presented previously [25].

Section snippets

Materials and methods

All experiments were performed in strict accordance with the guidelines established in The Guide for the Care and Use of Animals in Research (USPHS) and were approved by the University of Pittsburgh Animal Care and Use Committee. Male Sprague-Dawley rats (Zivic-Miller, Allison Park, PA, USA) weighing 275–400 g were anesthetized with chloral hydrate (400 mg/kg, i.p.) and placed in a stereotaxic device (Narishige). The lateral tail vein was catheterized for administration of drugs or supplemental

Results

In control rats, BENZ caused a significant decrease in DA cell firing rate (n = 13, F(5,60) = 6.51, p < 0.01; Fig. 1A, Fig. 2, dotted line); however, the effects of BENZ on burst firing were baseline dependent. Cells that fired <15% of their spikes in bursts during the baseline period (“nonbursty controls”; n = 7) increased their burst firing in response to BENZ, whereas cells that fired >15% of their spikes in bursts during the baseline period (“bursty controls”; n = 6) decreased their burst

Discussion

Although the effects of DAT inhibitors 2, 12, 13, 24 and the antimuscarinic trihexiphenidyl [7] on DA cell activity in vivo have been reported previously, to our knowledge this is the first report of the actions of BENZ on DA cell activity in vivo. In this regard, it is interesting to note the differences between our results and previous results obtained with DAT inhibitors and muscarinic drugs in vivo. Dopamine transporter inhibitors have been shown to decrease SN and VTA DA cell firing rate 2

Acknowledgements

This study was supported by USPHS MH 01055, MH 29670 and MH 42217 (A.A.G.) and Undergraduate Research Fellowships from Howard Hughes Medical Institute and NIMH (C.L.T.). The authors thank Mark Antkowiak for technical assistance.

References (28)

  • F.J. Ayd

    A survey of drug-induced extrapyramidal reactions

    JAMA

    (1961)
  • K. Batsche et al.

    5-HT3 receptor antagonists fail to block the suppressant effect of cocaine on the firing rate of A10 dopamine neurons in the rat

    Brain Res.

    (1992)
  • M.S. Brodie et al.

    Cocaine effects in the ventral tegmental areaEvidence for an indirect dopaminergic mechanism of action

    Naunyn-Schmiedebergs Arch. Pharmacol.

    (1990)
  • B.S. Bunney et al.

    Acute and chronic haloperidol treatmentComparison of effects on nigral dopaminergic cell activity

    Life Sci.

    (1978)
  • B.S. Bunney et al.

    Dopaminergic neuronsEffect of antipsychotic drugs and amphetamine on single cell activity

    J. Pharmacol. Exp. Ther.

    (1973)
  • D.E. Casey et al.

    Dopamine, acetylcholine, and GABA effects in acute dystonia in primates

    Psychopharmacol.

    (1980)
  • L.A. Chiodo et al.

    Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neurons

    J. Neurosci.

    (1985)
  • W.H. Church et al.

    Extracellular dopamine in rat striatum following uptake inhibition by cocaine, nomifensine, and benztropine

    Eur. J. Pharmacol.

    (1987)
  • R. Cortes et al.

    Muscarinic cholinergic receptor subtypes in rat brain, IQuantitative autoradiographic studies

    Brain Res.

    (1986)
  • R.B. Darlington

    Regression and linear models

    (1990)
  • C.M. Dersch et al.

    Studies of the biogenic amine transporters, 1Dopamine reuptake blockers inhibit 3[H]Mazindol binding to the dopamine transporter by a competitive mechanism: Preliminary evidence for different binding domains

    Neurochem. Res.

    (1994)
  • L.C. Einhorn et al.

    Electrophysiological effects of cocaine in the mesoaccumbens dopamine systemStudies in the ventral tegmental area

    J. Neurosci.

    (1988)
  • G. Engberg et al.

    Inhibition of dopamine reuptakeSignificance for nigral dopamine neuron activity

    Synapse

    (1997)
  • A.A. Grace et al.

    The control of firing pattern in nigral dopamine neuronsBurst firing

    J. Neurosci.

    (1984)
  • View full text